Name

Lintuzumab

Alternate Names

HuG1-M195
SGN 33
SGN-33

Abbreviations

MOAB HuG1-M195
MOAB HuM195

Category

Chemotherapy

Subcategory

Cytotoxic agent--Anti-CD33

NSC Number

None

Primary Site

AML
MDS

Histology

None

Remarks

Orphan drug for MDS, AML; Phase III for AML Anti-CD33 humanized recombinant monoclonal antibody

Coding

This drug should be coded
Glossary